Williams J R, Nokes D J, Anderson R M
Department of Zoology, University of Oxford.
J Epidemiol Community Health. 1996 Dec;50(6):667-73. doi: 10.1136/jech.50.6.667.
To compare the potential cost effectiveness of vaccination against hepatitis B virus (HBV) targeted at genitourinary clinic (GU) attendees with that of universal infant vaccination.
A mathematical model of sexual and perinatal transmission of HBV was used to compare the effectiveness among heterosexual and homosexual populations of programmes of mass infant vaccination and targeted immunisation of genitourinary medicine (GU) clinic attendees. Each was applied to 90% of the eligible population with differing assumptions about rates of compliance and seroconversion - problems of delivery (obtaining high compliance) was considered a significant drawback of targeted vaccination. Observed relationships between GU clinic attendance and sex partner change rates for heterosexuals and for homosexuals were used to define the rates of vaccination uptake within sexual activity risk groups.
England and Wales.
Model results showed that for heterosexuals universal infant vaccination became more effective than clinic based vaccination only approximately 40 years after the start of the programme and that the predicted cost effectiveness of GU clinic vaccination was greater at all times. For homosexuals, clinic vaccination was always more effective over the time frame considered, but by 50 years if it were carried out without prior screening it had become appreciably less cost effective than a mass infant programme. With prior screening in GU clinics this cost effectiveness deficit was only marginal.
Targeted vaccination might have a much greater potential than is realised at present, particularly if it were possible to improve compliance of clinic attendees. A fuller comparison between mass infant and targeted vaccination must await the specific inclusion in the model of other risk groups such as intravenous drug users. An important determinant of the relative merits of the two approaches is the relationship between rates of attendance and of changing sexual partners. Further research on this is required.
比较针对泌尿生殖科门诊患者的乙型肝炎病毒(HBV)疫苗接种与普遍的婴儿疫苗接种的潜在成本效益。
采用HBV性传播和围产期传播的数学模型,比较大规模婴儿疫苗接种计划和针对泌尿生殖医学(GU)门诊患者的靶向免疫接种在异性恋和同性恋人群中的效果。每种方法都应用于90%的符合条件的人群,并对依从率和血清转化率做出不同假设——递送问题(获得高依从性)被认为是靶向疫苗接种的一个重大缺点。利用观察到的异性恋和同性恋者在GU门诊就诊率与性伴侣更换率之间的关系,来确定性活动风险组内的疫苗接种率。
英格兰和威尔士。
模型结果显示,对于异性恋者,在该计划开始约40年后,普遍的婴儿疫苗接种才比基于门诊的疫苗接种更有效,而且预测在任何时候GU门诊疫苗接种的成本效益都更高。对于同性恋者,在考虑的时间范围内,门诊疫苗接种始终更有效,但如果在没有事先筛查的情况下进行,到50年时,其成本效益已明显低于大规模婴儿疫苗接种计划。如果在GU门诊进行事先筛查,这种成本效益差距仅为边际差距。
靶向疫苗接种可能具有比目前所认识到的更大的潜力,特别是如果能够提高门诊患者的依从性。大规模婴儿疫苗接种和靶向疫苗接种之间更全面的比较必须等待将其他风险组(如静脉吸毒者)具体纳入模型。这两种方法相对优点的一个重要决定因素是就诊率与更换性伴侣率之间的关系。对此需要进一步研究。